Steven E Shoelson Selected Research

Steven E Shoelson Research Topics

Disease

20	Inflammation (Inflammations) 10/2017 - 05/2002
15	Insulin Resistance 01/2017 - 04/2002
12	Type 2 Diabetes Mellitus (MODY) 10/2017 - 04/2002
7	Obesity 04/2016 - 08/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 11/2006
3	Overweight 10/2017 - 02/2008
3	Atherosclerosis 11/2013 - 11/2006
2	Coronary Disease (Coronary Heart Disease) 10/2017 - 01/2016
2	Sepsis (Septicemia) 01/2017 - 07/2014
2	Neoplasms (Cancer) 01/2017 - 10/2004
2	Atrophy 01/2017 - 01/2012
2	Tinnitus 01/2016 - 05/2008
2	Muscular Atrophy (Muscle Atrophy) 01/2012 - 10/2004
2	Hypertriglyceridemia 12/2011 - 05/2011
2	Lipodystrophy 01/2010 - 05/2002
1	Blister (Bulla) 01/2022
1	Prediabetic State (Prediabetes) 10/2017
1	Endotoxemia 07/2014
1	Diabetic Angiopathies (Diabetic Angiopathy) 04/2014
1	Glucose Intolerance 11/2013
1	Hyperglycemia 12/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2012
1	Pneumonia (Pneumonitis) 01/2012
1	Fibrosis (Cirrhosis) 02/2011
1	Hypoglycemia (Reactive Hypoglycemia) 03/2010
1	Cachexia 10/2004
1	Hyperinsulinism (Hyperinsulinemia) 08/2004
1	Hepatocellular Carcinoma (Hepatoma) 08/2004
1	Diabetes Mellitus 11/2002
1	Type 1 Maturity-Onset Diabetes of the Young 10/2002
1	Muscular Dystrophies (Muscular Dystrophy) 05/2002
1	Muscular Diseases (Myopathy) 05/2002
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 05/2002
1	Body Weight (Weight, Body) 05/2002

Drug/Important Bio-Agent (IBA)

10	salicylsalicylic acid (salsalate)IBA 10/2017 - 02/2008
9	SalicylatesIBA 04/2014 - 05/2002
7	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 05/2002
6	Insulin (Novolin)FDA Link 07/2014 - 04/2002
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
5	CytokinesIBA 07/2014 - 02/2005
4	Phosphotransferases (Kinase)IBA 02/2012 - 08/2004
4	NF-kappa B (NF-kB)IBA 01/2010 - 10/2004
3	LipidsIBA 05/2008 - 02/2005
3	I-kappa B KinaseIBA 02/2005 - 04/2002
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 01/2016
2	Pioglitazone (Actos)FDA Link 01/2013 - 06/2012
2	CholesterolIBA 02/2012 - 05/2002
2	Apolipoproteins E (ApoE)IBA 02/2012 - 05/2011
2	LipopolysaccharidesIBA 01/2012 - 01/2010
2	very low density lipoprotein triglycerideIBA 12/2011 - 05/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2011 - 05/2002
2	Biomarkers (Surrogate Marker)IBA 02/2011 - 05/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 02/2011 - 07/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2007 - 02/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2002 - 05/2002
1	Glycated Serum ProteinsIBA 10/2017
1	AdiponectinIBA 10/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	MyostatinIBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 04/2016
1	Neutralizing AntibodiesIBA 04/2016
1	AlbuminsIBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2014
1	Messenger RNA (mRNA)IBA 07/2014
1	InterleukinsIBA 07/2014
1	Caspase 3 (Caspase-3)IBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	Blood Proteins (Serum Proteins)IBA 04/2014
1	pentosidineIBA 04/2014
1	Hemoglobins (Hemoglobin)IBA 04/2014
1	Advanced Glycation End ProductsIBA 04/2014
1	Profilins (Profilin)IBA 11/2013
1	Microfilament Proteins (Actin Binding Proteins)IBA 11/2013
1	Retinaldehyde (Retinal)IBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012
1	2,4-thiazolidinedione (thiazolidinedione)IBA 06/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2012
1	UbiquitinIBA 01/2012
1	PolyubiquitinIBA 01/2012
1	ChemokinesIBA 02/2011
1	C-PeptideIBA 02/2008
1	Chloroquine (Aralen)FDA LinkGeneric 11/2006
1	Antimalarials (Antimalarial Agents)IBA 11/2006
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2004
1	Phorbol EstersIBA 08/2004
1	phorbolIBA 08/2004
1	Serine (L-Serine)FDA Link 08/2004
1	Indicators and Reagents (Reagents)IBA 08/2004
1	AntibodiesIBA 08/2004
1	AnisomycinIBA 08/2004
1	calyculin AIBA 08/2004
1	Insulin Receptor Substrate ProteinsIBA 08/2004
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 11/2002
1	LigandsIBA 10/2002
1	LaminsIBA 05/2002
1	Lamin Type A (Lamin A)IBA 05/2002

Therapy/Procedure

2	Denervation 01/2017 - 10/2004
1	Therapeutics 01/2016
1	Glycemic Control 03/2010